|
|
OGT |
O-linked N-acetylglucosamine (GlcNAc) transferase |
- HATs acetylate histones
- RIPK1-mediated regulated necrosis
- Regulation of necroptotic cell death
- UCH proteinases
- Formation of WDR5-containing histone-modifying complexes
|
|
|
|
|
PAFAH1B1 |
platelet activating factor acetylhydrolase 1b regulatory subunit 1 |
- Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal
- Separation of Sister Chromatids
- Resolution of Sister Chromatid Cohesion
- Regulation of PLK1 Activity at G2/M Transition
- Loss of Nlp from mitotic centrosomes
- Recruitment of mitotic centrosome proteins and complexes
- Loss of proteins required for interphase microtubule organization from the centrosome
- Recruitment of NuMA to mitotic centrosomes
- Anchoring of the basal body to the plasma membrane
- RHO GTPases Activate Formins
- COPI-independent Golgi-to-ER retrograde traffic
- Mitotic Prometaphase
- AURKA Activation by TPX2
- EML4 and NUDC in mitotic spindle formation
|
|
- Lissencephaly (LIS); Miller-Dieker syndrome (MDLS)
|
|
|
PGK1 |
phosphoglycerate kinase 1 |
- Glycolysis
- Gluconeogenesis
- Manipulation of host energy metabolism
|
- Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate
- 3-phospho-D-glyceric acid
- Copper
- Artenimol
|
- Anemia due to disorders of glycolytic enzymes, including: Hexokinase (HK) deficiency; Phosphoglycerate kinase 1 (PGK1) deficiency; Triose-phosphate isomerase (TPI) deficiency; Glucose phosphate isomerase (GPI) deficiency; Bisphosphoglycerate mutase (BPGM) deficiency
|
|
|
PLA2G7 |
phospholipase A2 group VII |
- Synthesis, secretion, and deacylation of Ghrelin
|
- Rilapladib
- (1R)-1,2,2-trimethylpropyl (R)-methylphosphinate
|
|
|
|
PLK2 |
polo like kinase 2 |
- TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain
- CD163 mediating an anti-inflammatory response
- NPAS4 regulates expression of target genes
|
|
|
|
|
S100A8 |
S100 calcium binding protein A8 |
- ER-Phagosome pathway
- MyD88:MAL(TIRAP) cascade initiated on plasma membrane
- MyD88 deficiency (TLR2/4)
- IRAK4 deficiency (TLR2/4)
- RHO GTPases Activate NADPH Oxidases
- Regulation of TLR by endogenous ligand
- Neutrophil degranulation
- Metal sequestration by antimicrobial proteins
|
- Calcium
- Zinc
- Copper
- Zinc acetate
- Zinc chloride
- Zinc sulfate, unspecified form
|
|
|
|
S100A9 |
S100 calcium binding protein A9 |
- ER-Phagosome pathway
- MyD88:MAL(TIRAP) cascade initiated on plasma membrane
- MyD88 deficiency (TLR2/4)
- IRAK4 deficiency (TLR2/4)
- RHO GTPases Activate NADPH Oxidases
- Regulation of TLR by endogenous ligand
- Neutrophil degranulation
- Metal sequestration by antimicrobial proteins
|
- Calcium
- Zinc
- Zinc acetate
- Zinc chloride
- Zinc sulfate, unspecified form
|
|
|
|
SDC3 |
syndecan 3 |
- Glycosaminoglycan-protein linkage region biosynthesis
- HS-GAG biosynthesis
- HS-GAG biosynthesis
- HS-GAG degradation
- Cell surface interactions at the vascular wall
- Syndecan interactions
- Syndecan interactions
- Defective B4GALT7 causes EDS, progeroid type
- Defective B3GAT3 causes JDSSDHD
- Defective EXT2 causes exostoses 2
- Defective EXT1 causes exostoses 1, TRPS2 and CHDS
- Defective B3GALT6 causes EDSP2 and SEMDJL1
- Attachment and Entry
- Attachment and Entry
- Retinoid metabolism and transport
- Respiratory syncytial virus (RSV) attachment and entry
- RSV-host interactions
|
|
|
|
|
SIAH1 |
siah E3 ubiquitin protein ligase 1 |
- Netrin-1 signaling
- Amyloid fiber formation
- Antigen processing: Ubiquitination & Proteasome degradation
|
|
|
|
|
SMN1 |
survival of motor neuron 1, telomeric |
- snRNP Assembly
- SARS-CoV-2 modulates host translation machinery
|
|
- Spinal muscular atrophy (SMA), including: SMA type I (SMA1) / Werdning-Hoffman disease; SMA type II (SMA2); SMA type III (SMA3) / Kugeleberg-Welander disease; SMA type IV (SMA4); X-linked SMA 2 (SMAX2); X-linked distal SMA 3 (DSMAX); Distal SMA autosomal recessive type 4 (DSMA4); Congenital distal spinal muscular atrophy (SMAL); SMA proximal adult autosomal dominant (SMAPAD)
|
|
|
SNCA |
synuclein alpha |
- Amyloid fiber formation
- PKR-mediated signaling
|
- Resveratrol
- Dequalinium
- Copper
|
- Lewy body dementia (LBD); Dementia with Lewy bodies (DLB)
- Parkinson's disease (PD)
|
|
|
SOCS6 |
suppressor of cytokine signaling 6 |
- Regulation of KIT signaling
- Neddylation
- Negative regulation of FLT3
|
|
|
|
|
SOCS7 |
suppressor of cytokine signaling 7 |
|
|
|
|
|
SPART |
spartin |
|
|
- Hereditary spastic paraplegia (SPG)
|
|
|
STARD13 |
StAR related lipid transfer domain containing 13 |
- RHOA GTPase cycle
- RHOB GTPase cycle
- RHOC GTPase cycle
- CDC42 GTPase cycle
|
|
|
|
|
STK11 |
serine/threonine kinase 11 |
- AMPK inhibits chREBP transcriptional activation activity
- Energy dependent regulation of mTOR by LKB1-AMPK
- Regulation of TP53 Activity through Phosphorylation
- FOXO-mediated transcription of cell death genes
|
|
- Peutz-Jeghers syndrome
- Pancreatic cancer
|
|
|
SYK |
spleen associated tyrosine kinase |
- GPVI-mediated activation cascade
- GPVI-mediated activation cascade
- FCGR activation
- FCGR activation
- Regulation of actin dynamics for phagocytic cup formation
- Role of phospholipids in phagocytosis
- DAP12 signaling
- Fc epsilon receptor (FCERI) signaling
- Fc epsilon receptor (FCERI) signaling
- Role of LAT2/NTAL/LAB on calcium mobilization
- Role of LAT2/NTAL/LAB on calcium mobilization
- FCERI mediated MAPK activation
- FCERI mediated Ca+2 mobilization
- FCERI mediated Ca+2 mobilization
- Integrin signaling
- CLEC7A (Dectin-1) signaling
- Dectin-2 family
- Dectin-2 family
- Interleukin-2 signaling
- Regulation of signaling by CBL
- Regulation of signaling by CBL
- FCGR3A-mediated IL10 synthesis
- FCGR3A-mediated phagocytosis
- Signaling by CSF3 (G-CSF)
- Signaling by CSF3 (G-CSF)
- Potential therapeutics for SARS
- Inactivation of CSF3 (G-CSF) signaling
- Inactivation of CSF3 (G-CSF) signaling
- FLT3 signaling through SRC family kinases
- Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
- Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
|
- Staurosporine
- N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide
- Tamatinib
- 2-{2-[(3,5-dimethylphenyl)amino]pyrimidin-4-yl}-N-[(1S)-2-hydroxy-1-methylethyl]-4-methyl-1,3-thiazole-5-carboxamide
- 2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide
- Ellagic acid
- Fostamatinib
- Entospletinib
|
|
|
|
SYTL4 |
synaptotagmin like 4 |
|
|
|
|
|
TAOK2 |
TAO kinase 2 |
|
- Dexfosfoserine
- Fostamatinib
|
|
|
|
TIMM17A |
translocase of inner mitochondrial membrane 17A |
- Mitochondrial protein import
- Mitochondrial protein import
- Mitochondrial protein degradation
|
|
|